Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion type Assertion NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_head.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion description "[In this regard, besides a strong association between the HLA-DRB1?04 shared epitope alleles and both endothelial dysfunction, an early step in the atherosclerotic process, and clinically evident CV disease, other polymorphisms belonging to genes implicated in inflammatory and metabolic pathways, located inside and outside the HLA region, such as the 308 variant (G > A, rs1800629) of the TNFA locus, the rs1801131 polymorphism (A > C; position + 1298) of the MTHFR locus, or a deletion of 32 base pairs on the CCR5 gene, seem to be associated with the risk of CV disease in patients with RA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_provenance.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion evidence source_evidence_literature NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_provenance.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion SIO_000772 22927710 NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_provenance.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion wasDerivedFrom befree-20150227 NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_provenance.
- NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_assertion wasGeneratedBy ECO_0000203 NP456017.RAamaYwG7A8_utqQfLD37PJCMVywvCu5oB3IFceQj-x6M130_provenance.